A prospective study of an aggressive warfarin dosing algorithm to reach and maintain INR 2 to 3 after heart valve surgery

Thrombosis and Haemostasis

Volumn 105, Issue 2, 2011, Pages 232-238

  Meijer, Karina ^a,b   Kim, Yang Ki ^a,c   Carter, Donna ^a   Schulman, Sam ^a  

^a HHS General Hospital   (Canada)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c Soonchunhyang University   (South Korea)

Author keywords

Cardiology; Management of disease; Stroke prevention

Indexed keywords

ACETYLSALICYLIC ACID; WARFARIN;

ADULT; AGED; ALGORITHM; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; CONTROLLED STUDY; DRUG DOSE REGIMEN; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEART VALVE SURGERY; HUMAN; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; THROMBOSIS;

AGED; ALGORITHMS; ANTICOAGULANTS; BLOOD COAGULATION; CARDIAC SURGICAL PROCEDURES; CHI-SQUARE DISTRIBUTION; DRUG ADMINISTRATION SCHEDULE; DRUG DOSAGE CALCULATIONS; DRUG MONITORING; FEMALE; HEART VALVE DISEASES; HEMORRHAGE; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; THROMBOSIS; TIME FACTORS; TREATMENT OUTCOME; WARFARIN;

EID: 79851502859     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH10-05-0324     Document Type: Article

References (19)

1. Salem DN, O'Gara PT, Madias C, et al. Valvular and structural heart disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133 (6 Suppl): 593S-629S.
2. Veeger NJ, Piersma-Wichers M, Hillege HL, et al. Early detection of patients with a poor response to vitamin K antagonists: the clinical impact of individual time within target range in patients with heart disease. J Thromb Haemost 2006; 4: 1625-1627.
3. Eitz T, Schenk S, Fritzsche D, et al. International normalized ratio self-management lowers the risk of thromboembolic events after prosthetic heart valve replacement. Ann Thorac Surg 2008; 85: 949-954.
4. Butchart EG, Payne N, Li HH, et al. Better anticoagulation control improves survival after valve replacement. J Thorac Cardiovasc Surg 2002; 123: 715-723. (Pubitemid 34535082)
5. Kulik A, Rubens FD, Wells PS, et al. Early postoperative anticoagulation after mechanical valve replacement: a systematic review. Ann Thorac Surg 2006; 81: 770-781. (Pubitemid 43120610)
6. Dunn AS, Turpie AG. Perioperative management of patients receiving oral anticoagulants: a systematic review. Arch Intern Med 2003; 163: 901-908. (Pubitemid 36522737)
7. Torn M, Rosendaal FR. Oral anticoagulation in surgical procedures: risks and recommendations. Br J Haematol 2003; 123: 676-682. (Pubitemid 37468065)
8. Ageno W, Turpie AG. Exaggerated initial response to warfarin following heart valve replacement. Am J Cardiol 1999; 84: 905-908. (Pubitemid 29475074)
9. Cade JF, Hirsh J, Clarebrough JK. Anticoagulants after open-heart surgery. Med J Aust 1970; 2: 5-6.
10. Meijer K, Kim YK, Schulman S. Decreasing warfarin sensitivity during the first three months after heart valve surgery: Implications for dosing. Thromb Res 2010; 125: 224-229.
11. Kim YK, Nieuwlaat R, Connolly SJ, et al. Effect of a simple two-step warfarin dosing algorithm on anticoagulant control as measured by time in therapeutic range: a pilot study. J Thromb Haemost 2010; 8: 101-106.
12. Schulman S, Kearon C. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost 2005; 3: 692-694. (Pubitemid 41647882)
13. Rosendaal FR, Cannegieter SC, van der Meer FJ, et al. A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost 1993; 69: 236-239. (Pubitemid 23069000)
14. Veeger NJ, Piersma-Wichers M, Tijssen JG, et al. Individual time within target range in patients treated with vitamin K antagonists: main determinant of quality of anticoagulation and predictor of clinical outcome. A retrospective study of 2300 consecutive patients with venous thromboembolism. Br J Haematol 2005; 128: 513-519. (Pubitemid 40283170)
15. Chatellier G, Colombet I, Degoulet P. Computer-adjusted dosage of anticoagulant therapy improves the quality of anticoagulation. Stud Health Technol Inform 1998; 52: 819-823.
16. Poller L, Keown M, Ibrahim S, et al. A multicentre randomised clinical endpoint study of PARMA 5 computer-assisted oral anticoagulant dosage. Br J Haematol 2008; 143: 274-283.
17. Poller L, Keown M, Ibrahim S, et al. A multicentre randomised assessment of the DAWN AC computer-assisted oral anticoagulant dosage program. Thromb Haemost 2009; 101: 487-494.
18. Aramendi JI, Mestres CA, Martinez-Leon J, et al. Triflusal versus oral anticoagulation for primary prevention of thromboembolism after bioprosthetic valve replacement (trac): prospective, randomized, co-operative trial. Eur J Cardiothorac Surg 2005; 27: 854-860. (Pubitemid 40585681)
19. Ansell J, Hirsh J, Hylek E, et al. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133 (6 Suppl): 160S-198S.